1. 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants. (9th November 2020) Authors: Booty, Matthew; Stockmann, Adam; Pryor, Olivia; Myint, Melissa; Trumpfheller, Christine; Nicolini, Valeria; Klein, Christian; Codarri, Laura; Umana, Pablo; Sharei, Armon; Bernstein, Howard; Seidl, Katherine; Loughhead, Scott Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. (December 2018) Authors: Peterson, Laurence B.; Bell, Charles J.M.; Howlett, Sarah K.; Pekalski, Marcin L.; Brady, Kevin; Hinton, Heather; Sauter, Denise; Todd, John A.; Umana, Pablo; Ast, Oliver; Waldhauer, Inja; Freimoser-Grundschober, Anne; Moessner, Ekkehard; Klein, Christian; Hosse, Ralf J.; Wicker, Linda S. Journal: Journal of autoimmunity Issue: Volume 95(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antitumour activity of the glycoengineered type II anti‐CD20 antibody obinutuzumab (GA101) in combination with the MDM2‐selective antagonist idasanutlin (RG7388). (18th April 2016) Authors: Herting, Frank; Herter, Sylvia; Friess, Thomas; Muth, Gunther; Bacac, Marina; Sulcova, Jitka; Umana, Pablo; Dangl, Markus; Klein, Christian Journal: European journal of haematology Issue: Volume 97:Number 5(2016:Nov.) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins. Issue 1 (1st January 2020) Authors: Jost, Christian; Darowski, Diana; Challier, John; Pulko, Vesna; Hanisch, Lydia J; Xu, Wei; Mössner, Ekkehard; Bujotzek, Alexander; Klostermann, Stefan; Umana, Pablo; Kontermann, Roland E.; Klein, Christian Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors. (2nd August 2016) Authors: Bacac, Marina; Klein, Christian; Umana, Pablo Journal: Oncoimmunology Issue: Volume 5:Number 8(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors. Issue 7 (28th July 2022) Authors: Stock, Sophia; Benmebarek, Mohamed-Reda; Kluever, Anna-Kristina; Darowski, Diana; Jost, Christian; Stubenrauch, Kay-Gunnar; Benz, Joerg; Freimoser-Grundschober, Anne; Moessner, Ekkehard; Umana, Pablo; Subklewe, Marion; Endres, Stefan; Klein, Christian; Kobold, Sebastian Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combination therapy with the type II anti-CD20 antibody obinutuzumab. (3rd October 2017) Authors: Klein, Christian; Bacac, Marina; Umana, Pablo; Fingerle-Rowson, Günter Journal: Expert opinion on investigational drugs Issue: Volume 26:Number 10(2017) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Detection of antidrug antibodies against human therapeutic antibodies lacking Fc-effector functions by usage of soluble Fcγ receptor I. (October 2016) Authors: Wessels, Uwe; Poehler, Alexander; Moheysen-Zadeh, Miriam; Zadak, Markus; Staack, Roland F; Umana, Pablo; Heinrich, Julia; Stubenrauch, Kay Journal: Bioanalysis Issue: Volume 8:Number 20(2016) Page Start: 2135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma. Issue 9 (September 2014) Authors: Herting, Frank; Friess, Thomas; Bader, Sabine; Muth, Gunter; Hölzlwimmer, Gabriele; Rieder, Natascha; Umana, Pablo; Klein, Christian Journal: Leukemia & lymphoma Issue: Volume 55:Issue 9(2014:Sep.) Page Start: 2151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor. (1st February 2016) Authors: Schreiner, Jens; Thommen, Daniela S.; Herzig, Petra; Bacac, Marina; Klein, Christian; Roller, Andreas; Belousov, Anton; Levitsky, Victor; Savic, Spasenija; Moersig, Wolfgang; Uhlenbrock, Franziska; Heinzelmann-Schwarz, Viola A.; Umana, Pablo; Pisa, Pavel; Lardinois, Didier; Müller, Philipp; Karan... Journal: Oncoimmunology Issue: Volume 5:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗